{"database": "lobbying", "table": "lobbying_activities", "rows": [[988139, "b5f81920-cd21-4c29-a761-a1927fc1c75a", "Q3", "CHAMBER HILL STRATEGIES", 400645947, "BOEHRINGER-INGELHEIM PHARMACEUTICALS, INC.", 2010, "third_quarter", "CPT", "Provisions related to patent settlements in various House and Senate appropriations bills including H.R. 4899, Emergency Supplemental Appropriations for FY10, and the Senate version of FY11 Appropriations for Financial Services", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2010-10-06T12:12:48.830000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["988139"], "units": {}, "query_ms": 96.38978901784867, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}